When the high cost of branded drugs becomes a treatment barrier, the Dacomitinib version manufactured by Laos Big Bear Pharmaceutical builds a bridge ···【Read More】
Update: 2026-06-11Source: Haiou HealthViews: 76
As a second-generation EGFR tyrosine kinase inhibitor, Dacomitinib plays a key role in the treatment of non-small cell lung cancer, and the Laos Dabea···【Read More】
Update: 2026-06-11Source: Haiou HealthViews: 74
Для пациентов с раком легких, испытывающих финансовые трудности, непатентованная версия дакомитиниба, выпущенная компанией Lao Big Bear Pharmaceutical···【Read More】
Update: 2026-06-11Source: Haiou HealthViews: 76
As a potent and highly selective MEK1/2 inhibitor, the Lao Big Bear version of Cobimetinib has demonstrated a clinical response rate and safety profil···【Read More】
Update: 2026-06-11Source: Haiou HealthViews: 76
The Laos Dabear version of Cobimetinib, as the first generic alternative to the original drug "Cobimetinib" in the Southeast Asian region, i···【Read More】
Update: 2026-06-11Source: Haiou HealthViews: 74
With the accessibility of targeted anticancer drugs receiving increasing attention, the generic version of Cobimetinib launched by Lao Bear Pharmaceut···【Read More】
Update: 2026-06-11Source: Haiou HealthViews: 75
Laos Daxiong version of Avatrombopag, as a novel thrombopoietin receptor agonist, provides a convenient and effective oral treatment option for patien···【Read More】
Update: 2026-06-10Source: Haiou HealthViews: 77
The Lao Big Bear version of Avatrombopag is a compliantly manufactured generic drug, providing patients with thrombocytopenia a treatment option that ···【Read More】
Update: 2026-06-09Source: Haiou HealthViews: 79
As a targeted drug focusing on the core pathological link of thrombocytosis, the Lao Big Bear version of Anagrelide not only continues the efficacy me···【Read More】
Update: 2026-06-05Source: Haiou HealthViews: 97
The Lao Bear version of Anagrelide is an oral antiproliferative drug for essential thrombocythemia, which precisely reduces platelet count by inhibiti···【Read More】
Update: 2026-06-05Source: Haiou HealthViews: 94
In the treatment landscape for elevated platelet counts caused by myeloproliferative neoplasms, the Laos Daxiong version of Anagrelide,凭借规范的仿制工艺与与原研药等···【Read More】
Update: 2026-06-05Source: Haiou HealthViews: 95
The Ibrutinib (ILUDX) produced by Laos Big Bear Pharmaceuticals is a high-quality oral BTK inhibitor generic drug. While retaining the same core ingre···【Read More】
Update: 2026-06-05Source: Haiou HealthViews: 100
While the insured price of the imported original drug Ibrutinib can still be several thousand yuan per box, the Lao Big Bear Pharmaceutical version ha···【Read More】
Update: 2026-06-05Source: Haiou HealthViews: 93
The Lao Bear Pharmaceuticals version of Ibrutinib, brand name ILUDX, is an oral BTK inhibitor used to treat various B-cell malignancies, offering a mo···【Read More】
Update: 2026-06-05Source: Haiou HealthViews: 95
The appearance of the Lao Dabear version of Mobocertinib has not only broken the monopoly of high-priced original drugs but has also become a highly a···【Read More】
Update: 2026-06-04Source: Haiou HealthViews: 94
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos